Mechanism difference Semaglutide (GLP-1 agonist): appetite regulation, satiety, improved glycemic control (New England Journal of Medicine) Tirzepatide (GLP-1/GIP agonist): broader incretin effects, robust appetite/weight effects (New England Journal of Medicine) AOD-9604: targeted fat-metabolism signaling
The goal is no longer just to kill the pathogen but to support the entire system's ability to withstand the threat, tolerate the treatment, and recover rapidly
Mast cell stabilisers, including cromolyn and more recently developed synthetic compounds, are used in clinical settings to control allergic responses 56 which are highly reliant on mast cell degranulation and activation
Complete blood counts and comprehensive metabolic panels at baseline and periodic intervals could detect any unexpected hematological or organ toxicity, though preclinical data suggests low risk
Doses and ingredients could be different to whats on the label, and they could be contaminated with all sorts of dangerous things
Pablo N